SciSparc's Board of Directors Provides Strategic Decision

09.06.2022 - TEL AVIV, Israel, June 09, 2022 (GLOBE NEWSWIRE) - SciSparc Ltd. (Nasdaq: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the 'Company' or ...

Related Keywords

Oz Adler ,Exchange Commission ,Scisparc Ltd ,Chief Executive ,Looking Statements ,Private Securities Litigation Reform Act ,Annual Report ,